BioElectronics Corporation (BIEL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.52 Million USD | 2.78% |
| 2022 | 12.19 Million USD | 31.51% |
| 2021 | 9.27 Million USD | 38.28% |
| 2020 | 6.7 Million USD | 18.94% |
| 2019 | 5.63 Million USD | 20.26% |
| 2018 | 4.68 Million USD | -16.2% |
| 2017 | 5.59 Million USD | 20.06% |
| 2016 | 4.65 Million USD | 13.11% |
| 2015 | 4.11 Million USD | -27.97% |
| 2014 | 5.71 Million USD | 1.68% |
| 2013 | 5.62 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | - USD | -100.0% |
| 2023 Q1 | 12.52 Million USD | 2.75% |
| 2023 FY | 12.52 Million USD | 2.78% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | 8.5 Million USD | -8.25% |
| 2022 FY | 12.19 Million USD | 31.51% |
| 2022 Q4 | 12.19 Million USD | 29.29% |
| 2022 Q3 | 9.42 Million USD | 4.91% |
| 2022 Q2 | 8.98 Million USD | 5.67% |
| 2021 Q3 | 8.66 Million USD | 18.95% |
| 2021 FY | 9.27 Million USD | 38.28% |
| 2021 Q4 | 9.27 Million USD | 7.03% |
| 2021 Q1 | 7.36 Million USD | 9.87% |
| 2021 Q2 | 7.28 Million USD | -1.14% |
| 2020 Q4 | 6.7 Million USD | 0.0% |
| 2020 Q2 | 6.75 Million USD | 3.26% |
| 2020 Q1 | 6.54 Million USD | 16.05% |
| 2020 FY | 6.7 Million USD | 18.94% |
| 2019 Q4 | 5.63 Million USD | 48.85% |
| 2019 Q3 | 3.78 Million USD | -22.49% |
| 2019 Q2 | 4.88 Million USD | -20.97% |
| 2019 FY | 5.63 Million USD | 20.26% |
| 2019 Q1 | 6.18 Million USD | 31.89% |
| 2018 Q2 | 5.78 Million USD | 4.37% |
| 2018 Q1 | 5.53 Million USD | -0.96% |
| 2018 FY | 4.68 Million USD | -16.2% |
| 2018 Q4 | 4.68 Million USD | -23.62% |
| 2018 Q3 | 6.13 Million USD | 6.15% |
| 2017 Q2 | 4.25 Million USD | 9.91% |
| 2017 Q4 | 5.59 Million USD | 0.0% |
| 2017 FY | 5.59 Million USD | 20.06% |
| 2017 Q1 | 3.87 Million USD | -16.91% |
| 2016 Q1 | 4.22 Million USD | 2.69% |
| 2016 FY | 4.65 Million USD | 13.11% |
| 2016 Q2 | 3.59 Million USD | -14.9% |
| 2016 Q4 | 4.65 Million USD | 26.98% |
| 2016 Q3 | 3.66 Million USD | 1.94% |
| 2015 FY | 4.11 Million USD | -27.97% |
| 2015 Q4 | 4.11 Million USD | 79.87% |
| 2015 Q3 | 2.28 Million USD | -43.09% |
| 2015 Q2 | 4.02 Million USD | -24.2% |
| 2015 Q1 | 5.3 Million USD | -7.17% |
| 2014 Q2 | 5.79 Million USD | -0.57% |
| 2014 Q1 | 5.83 Million USD | 3.68% |
| 2014 FY | 5.71 Million USD | 1.68% |
| 2014 Q4 | 5.71 Million USD | -4.03% |
| 2014 Q3 | 5.95 Million USD | 2.77% |
| 2013 Q3 | 4.66 Million USD | 51.72% |
| 2013 Q4 | 5.62 Million USD | 20.62% |
| 2013 FY | 5.62 Million USD | 0.0% |
| 2013 Q2 | 3.07 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Avitar, Inc. | 3.89 Million USD | -221.565% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -7682.38% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -10696.38% |
| Polarean Imaging plc | 74.84 Thousand USD | -16640.549% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -2687.565% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 95.982% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 33.571% |
| Össur hf. | 311.8 Million USD | 95.982% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -1927.448% |
| Escalon Medical Corp. | 279.4 Thousand USD | -4384.414% |
| Aurora Spine Corporation | 1.59 Million USD | -687.13% |
| BrainsWay Ltd. | 239 Thousand USD | -5142.523% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 24.999% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 98.461% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -5657.811% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -28587.68% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -2023.666% |
| Nanomix Corporation | 10.11 Million USD | -23.915% |
| Theraclion SA | 1.95 Million EUR | -542.303% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -4013.47% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -8253.087% |
| Lombard Medical, Inc. | 28.02 Million USD | 55.291% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 85.962% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -5050.144% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -8703.287% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -2446.673% |
| VMS Rehab Systems, Inc. | 106.45 USD | -11770337.764% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -2351.983% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -2253.973% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -1458.412% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -3786.338% |
| Urologix, Inc. | 4.58 Million USD | -173.215% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -2812.276% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -349.682% |
| SS Innovations International, Inc. | 1.91 Million USD | -555.853% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.423% |
| NIOX Group Plc | 500 Thousand USD | -2405.926% |
| Fuse Medical, Inc. | 200 Thousand USD | -6164.816% |
| Broncus Holding Corporation | 1.22 Million USD | -923.663% |
| Brain Scientific Inc. | 7378.00 USD | -169724.221% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -7640.839% |
| Health Logic Interactive Inc. | - USD | -Infinity% |